Chaus Fahad M, Craig Miguel, Bracamonte Erika, Sundararajan Srinath, Lee Benjamin R
Division of Urology, University of Arizona College of Medicine Tucson, Tucson, Arizona.
Department of Medical Imaging, University of Arizona College of Medicine Tucson, Tucson, Arizona.
J Endourol Case Rep. 2019 Dec 2;5(4):151-153. doi: 10.1089/cren.2019.0031. eCollection 2019.
Primary malignant melanoma (PMM) of the urinary tract is a rare entity, with only 28 cases reported in the literature. We present an interesting case of a 27-year-old Caucasian woman, with family history of melanoma, who initially presented with gross hematuria, and was subsequently found to have PMM of the bladder. Initially diagnosis was made through transurethral resection of the bladder tumor with clinical suspicion of residual disease in the patient. Subsequently, she underwent robotic partial cystectomy with pelvic lymph node dissection followed by 1 year of pembrolizumab, a PD-1 checkpoint inhibitor. Subsequent imaging demonstrated no evidence of metastatic disease or local recurrence. This case report presents a unique management of a rare pathological diagnosis with the use of robotic partial cystectomy, and a PD-1 checkpoint inhibitor therapy that ultimately has led to a 2-year recurrence-free survival period for this young patient.
原发性尿路恶性黑色素瘤(PMM)是一种罕见的疾病,文献中仅报道了28例。我们报告了一例有趣的病例,一名27岁的白种女性,有黑色素瘤家族史,最初表现为肉眼血尿,随后被发现患有膀胱PMM。最初通过经尿道膀胱肿瘤切除术进行诊断,临床怀疑患者有残留疾病。随后,她接受了机器人辅助部分膀胱切除术及盆腔淋巴结清扫术,之后接受了1年的帕博利珠单抗治疗,这是一种PD-1检查点抑制剂。随后的影像学检查未发现转移疾病或局部复发的证据。本病例报告展示了对罕见病理诊断采用机器人辅助部分膀胱切除术及PD-1检查点抑制剂治疗的独特管理方法,最终使这位年轻患者获得了2年无复发生存期。